In situ ELISA for the evaluation of antiviral compounds effective against human cytomegalovirus (Q68280427)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1667788%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

title

In situ ELISA for the evaluation of antiviral compounds effective against human cytomegalovirus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1667788%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

author name string

W. A. Tatarowicz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1667788

24 October 2022

N. S. Lurain

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1667788

24 October 2022

K. D. Thompson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1667788

24 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1667788

24 October 2022

publication date

1 November 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1667788%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

23 September 2019

https://api.elsevier.com/content/article/PII:016609349190136N?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90136-N

https://api.elsevier.com/content/article/PII:016609349190136N?httpAccept=text/plain

24 October 2022

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90136-N

Journal of Virological Methods

24 October 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1667788%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1667788%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1667788%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

207-215

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1667788%20AND%20SRC:MED&resulttype=core&format=json

Evaluation of herpes simplex virus susceptibility to acyclovir using an enzyme-linked immunosorbent assay

23 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90136-N

Use of an enzyme-linked immunosorbent assay performed directly on fixed infected cell monolayers for evaluating drugs against varicella-zoster virus

24 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90136-N

Rapid antiviral DNA-DNA hybridization assay for human cytomegalovirus.

24 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90136-N

Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients

24 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90136-N

Acquisition of cytomegalovirus infection: an update

24 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90136-N

Nucleic acid hybridization for measurement of effects of antiviral compounds on human cytomegalovirus DNA replication

24 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90136-N

In situ enzyme immunoassay for antiviral susceptibility testing of respiratory syncytial virus

24 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90136-N

A colorimetric assay for the measurement of the sensitivity of herpes simplex viruses to antiviral agents

24 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90136-N

Rapid quantitative assay of cytomegalovirus infectivity

24 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90136-N

Rapid herpes simplex virus susceptibility testing using an enzyme-linked immunosorbent assay performed in situ on fixed virus-infected monolayers

24 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90136-N

Comparative inhibitory effects of nucleoside analogues on different clinical isolates of human cytomegalovirus in vitro

24 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90136-N

Monoclonal antibody for rapid laboratory detection of cytomegalovirus infections: characterization and diagnostic application

24 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90136-N

Evaluation of varicella-zoster antiviral drugs by a nucleic acid hybridization assay

24 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90136-N

Screening with a shell vial assay for antiviral activity against cytomegalovirus.

24 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90136-N

2'-Nor-cGMP: a seco-cyclic nucleotide with powerful anti-DNA-viral activity

24 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90136-N

Cytomegalovirus and the acquired immunodeficiency syndrome

24 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90136-N

Evolution of therapy for cytomegalovirus infection

24 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0166-0934(91)90136-N

24 October 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1667788%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference